These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 9185783)

  • 1. Fialuridine toxicity.
    Schmid R
    Hepatology; 1997 Jun; 25(6):1548. PubMed ID: 9185783
    [No Abstract]   [Full Text] [Related]  

  • 2. Blaming somebody else.
    Nature; 1994 Sep; 371(6493):89-90. PubMed ID: 8072549
    [No Abstract]   [Full Text] [Related]  

  • 3. Deaths bring clinical trials under scrutiny in Japan.
    Swinbanks D
    Nature; 1994 Jun; 369(6483):697. PubMed ID: 8008052
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe toxicity of fialuridine (FIAU).
    Josephson L
    N Engl J Med; 1996 Apr; 334(17):1135-6; author reply 1137-8. PubMed ID: 8598880
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe toxicity of fialuridine (FIAU).
    Lewis W; Perrino FW
    N Engl J Med; 1996 Apr; 334(17):1136; author reply 1137-8. PubMed ID: 8598881
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe toxicity of fialuridine (FIAU).
    Prince AM
    N Engl J Med; 1996 Apr; 334(17):1136; author reply 1137-8. PubMed ID: 8598882
    [No Abstract]   [Full Text] [Related]  

  • 7. Severe toxicity of fialuridine (FIAU).
    Gordon M
    N Engl J Med; 1996 Apr; 334(17):1136-7; author reply 1137-8. PubMed ID: 8598883
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection.
    Tennant BC; Baldwin BH; Graham LA; Ascenzi MA; Hornbuckle WE; Rowland PH; Tochkov IA; Yeager AE; Erb HN; Colacino JM; Lopez C; Engelhardt JA; Bowsher RR; Richardson FC; Lewis W; Cote PJ; Korba BE; Gerin JL
    Hepatology; 1998 Jul; 28(1):179-91. PubMed ID: 9657111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe toxicity of fialuridine (FIAU).
    Bari A
    N Engl J Med; 1996 Apr; 334(17):1135; author reply 1137-8. PubMed ID: 8598879
    [No Abstract]   [Full Text] [Related]  

  • 10. Histopathologic changes associated with fialuridine hepatotoxicity.
    Kleiner DE; Gaffey MJ; Sallie R; Tsokos M; Nichols L; McKenzie R; Straus SE; Hoofnagle JH
    Mod Pathol; 1997 Mar; 10(3):192-9. PubMed ID: 9071726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicology. 'Humanized' mouse detects deadly drug side effects.
    Cohen J
    Science; 2014 Apr; 344(6181):244-5. PubMed ID: 24744351
    [No Abstract]   [Full Text] [Related]  

  • 12. The utility of a differentiated preclinical liver model, HepaRG cells, in investigating delayed toxicity via inhibition of mitochondrial-replication induced by fialuridine.
    Jolly CE; Douglas O; Kamalian L; Jenkins RE; Beckett AJ; Penman SL; Williams DP; Monshouwer M; Simic D; Snoeys J; Park BK; Chadwick AE
    Toxicol Appl Pharmacol; 2020 Sep; 403():115163. PubMed ID: 32730777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deaths in US fialuridine trial.
    Brahams D
    Lancet; 1994 Jun; 343(8911):1494-5. PubMed ID: 7911188
    [No Abstract]   [Full Text] [Related]  

  • 14. A possible mechanism of eighteen patient deaths caused by interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs.
    Okuda H; Ogura K; Kato A; Takubo H; Watabe T
    J Pharmacol Exp Ther; 1998 Nov; 287(2):791-9. PubMed ID: 9808711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The need for improving information systems on drug interactions in Japan.
    Harada K; Fujimura A
    Arch Intern Med; 2000 Jul; 160(13):2063-4. PubMed ID: 10888985
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative in vitro and in vivo cytotoxic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and its arabinosyl derivative, (E)-5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil (BVaraU), against tumor cells expressing either the Varicella zoster or the Herpes simplex virus thymidine kinase.
    Grignet-Debrus C; Cool V; Baudson N; Degrève B; Balzarini J; De Leval L; Debrus S; Velu T; Calberg-Bacq CM
    Cancer Gene Ther; 2000 Feb; 7(2):215-23. PubMed ID: 10770629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of netivudine in haemodialysis patients.
    Le Roy F; Godin M; Legallicler B; Fillastre JP; Bidault R; Posner J; Peck RW
    J Antimicrob Chemother; 1996 Nov; 38(5):913-5. PubMed ID: 8961067
    [No Abstract]   [Full Text] [Related]  

  • 18. Mitochondrial toxicity in HIV-HCV coinfection: It depends on the choice of antiretroviral drugs?
    Bruno R; Sacchi P; Filice G
    Hepatology; 2002 Feb; 35(2):500-1. PubMed ID: 11826431
    [No Abstract]   [Full Text] [Related]  

  • 19. Letter to the editor.
    Pomper MG
    Semin Nucl Med; 2009 Sep; 39(5):354. PubMed ID: 19646560
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
    Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP
    J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.